296 related articles for article (PubMed ID: 15095700)
1. [Urinary tract infection and fluoroquinolone resistance].
Luisoni A; Cometta A
Rev Med Suisse Romande; 2003 Mar; 123(3):155-7. PubMed ID: 15095700
[TBL] [Abstract][Full Text] [Related]
2. Fluoroquinolone-resistant Escherichia coli in the long-term care setting.
Cohen AE; Lautenbach E; Morales KH; Linkin DR
Am J Med; 2006 Nov; 119(11):958-63. PubMed ID: 17071164
[TBL] [Abstract][Full Text] [Related]
3. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients.
Urbánek K; Kolár M; Strojil J; Koukalová D; Cekanová L; Hejnar P
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):741-5. PubMed ID: 15880441
[TBL] [Abstract][Full Text] [Related]
4. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
Johnson L; Sabel A; Burman WJ; Everhart RM; Rome M; MacKenzie TD; Rozwadowski J; Mehler PS; Price CS
Am J Med; 2008 Oct; 121(10):876-84. PubMed ID: 18823859
[TBL] [Abstract][Full Text] [Related]
5. Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates.
Caron F; Etienne M
Am J Med; 2010 Mar; 123(3):e13. PubMed ID: 20193811
[No Abstract] [Full Text] [Related]
6. Comparison of minimum inhibitory concentration values for fluoroquinolones against Escherichia coli causing urinary tract infection in both hospitalized patients and outpatients.
Tayfour M; Yuce A; Yulug N
Saudi Med J; 2001 Oct; 22(10):848-51. PubMed ID: 11744939
[TBL] [Abstract][Full Text] [Related]
7. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli.
Gagliotti C; Buttazzi R; Sforza S; Moro ML;
J Infect; 2008 Sep; 57(3):179-84. PubMed ID: 18707763
[TBL] [Abstract][Full Text] [Related]
8. Role of host and bacterial virulence factors in Escherichia coli spontaneous bacterial peritonitis.
Cereto F; Herranz X; Moreno E; Andreu A; Vergara M; Fontanals D; Roget M; Simó M; González A; Prats G; Genescà J
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):924-9. PubMed ID: 18794608
[TBL] [Abstract][Full Text] [Related]
9. Emergence of fluoroquinolone resistance in Escherichia coli isolates at the department of clinical hematology.
Zemkova M; Kotlarova J; Merka V; Cermak P; Vlcek J; Jebavy L
New Microbiol; 2007 Oct; 30(4):423-30. PubMed ID: 18080678
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
11. Empiric treatment of uncomplicated urinary tract infection with fluoroquinolones in older women in Israel: another lost treatment option?
Kahan NR; Chinitz DP; Waitman DA; Dushnitzky D; Kahan E; Shapiro M
Ann Pharmacother; 2006 Dec; 40(12):2223-7. PubMed ID: 17105833
[TBL] [Abstract][Full Text] [Related]
12. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
[TBL] [Abstract][Full Text] [Related]
13. [Fluoroquinolone resistance of human pathogenic bacteria. Resistant E coli now appearing in Sweden].
Osterlund A; Olsson-Liljequist B
Lakartidningen; 1999 Apr; 96(16):1965-6. PubMed ID: 10330864
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for quinolone-resistance in women presenting with Escherichia coli acute pyelonephritis.
Bedoin M; Cazorla C; Lucht F; Berthelot P; Boyer M; Carricajo A; Guérin T; Viallon A
Med Mal Infect; 2014 May; 44(5):206-16. PubMed ID: 24794820
[TBL] [Abstract][Full Text] [Related]
15. [Quinolone resistance in Gram negative rods in Iceland and association with antibiotic use].
Jónsdóttir K; Kristinsson KG
Laeknabladid; 2008 Apr; 94(4):279-85. PubMed ID: 18460726
[TBL] [Abstract][Full Text] [Related]
16. Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals.
MacDougall C; Powell JP; Johnson CK; Edmond MB; Polk RE
Clin Infect Dis; 2005 Aug; 41(4):435-40. PubMed ID: 16028149
[TBL] [Abstract][Full Text] [Related]
17. Finding the path of least antimicrobial resistance in pyelonephritis.
Lautenbach E
Clin Infect Dis; 2008 Nov; 47(9):1159-61. PubMed ID: 18808350
[No Abstract] [Full Text] [Related]
18. Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections.
Shah A; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193655
[TBL] [Abstract][Full Text] [Related]
19. The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.
Bolon MK; Wright SB; Gold HS; Carmeli Y
Antimicrob Agents Chemother; 2004 Jun; 48(6):1934-40. PubMed ID: 15155181
[TBL] [Abstract][Full Text] [Related]
20. National trends in emergency department antibiotic prescribing for elders with urinary tract infection, 1996-2005.
Caterino JM; Weed SG; Espinola JA; Camargo CA
Acad Emerg Med; 2009 Jun; 16(6):500-7. PubMed ID: 19245373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
